These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 19422046)

  • 1. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
    Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atelocollagen-mediated intravenous siRNA delivery specific to tumor tissues orthotopically xenografted in prostates of nude mice and its anticancer effects.
    Yuan Y; Makita N; Cao D; Mihara K; Kadomatsu K; Takei Y
    Nucleic Acid Ther; 2015 Apr; 25(2):85-94. PubMed ID: 25692652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA-Based Drug Targeting Human Bcl-xL Against Cancers.
    Takei Y
    Methods Mol Biol; 2019; 1974():31-40. PubMed ID: 31098993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atelocollagen-mediated in vivo siRNA transfection in ovarian carcinoma is influenced by tumor site, siRNA target and administration route.
    Meryet-Figuière M; Lecerf C; Varin E; Coll JL; Louis MH; Dutoit S; Giffard F; Blanc-Fournier C; Hedir S; Vigneron N; Brotin E; Pelletier L; Josserand V; Denoyelle C; Poulain L
    Oncol Rep; 2017 Oct; 38(4):1949-1958. PubMed ID: 28791387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
    Rieger C; Huebner D; Temme A; Wirth MP; Fuessel S
    Int J Oncol; 2015 Sep; 47(3):1121-30. PubMed ID: 26201840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
    BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Bcl-xL expression by a novel tumor-specific RNA interference system inhibits proliferation and enhances radiosensitivity in prostatic carcinoma cells.
    Wang R; Lin F; Wang X; Gao P; Dong K; Wei SH; Cheng SY; Zhang HZ
    Cancer Chemother Pharmacol; 2008 May; 61(6):943-52. PubMed ID: 17653717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-XL small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma cells.
    Lei X; Huang Z; Zhong M; Zhu B; Tang S; Liao D
    Acta Biochim Biophys Sin (Shanghai); 2007 May; 39(5):344-50. PubMed ID: 17492131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.
    Yu X; Yang L; Cairns MJ; Dass C; Saravolac E; Li X; Sun LQ
    Oncotarget; 2014 Oct; 5(19):9039-48. PubMed ID: 25344863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.
    Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts.
    Takei Y; Kadomatsu K; Goto T; Muramatsu T
    Cancer; 2006 Aug; 107(4):864-73. PubMed ID: 16832814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
    Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
    Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
    Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
    Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressing the growth of rectal cancer xenografts derived from patient tumors by an adenovector expressing small hairpin RNA targeting Bcl-XL.
    Zhu H; Zhou W; Hu J; Huang Z; Lao W; Huang X; He C
    J Gene Med; 2012 Dec; 14(12):761-8. PubMed ID: 23169477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER; Arlotti JA; Marynowski SW; Singh SV
    Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells.
    Yang J; Sun M; Zhang A; Lv C; De W; Wang Z
    World J Surg Oncol; 2011 Oct; 9():117. PubMed ID: 21970601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer.
    Zhu H; Zhu Y; Hu J; Hu W; Liao Y; Zhang J; Wang D; Huang X; Fang B; He C
    Int J Cancer; 2007 Sep; 121(6):1366-72. PubMed ID: 17534896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.
    Forootan SS; Bao ZZ; Forootan FS; Kamalian L; Zhang Y; Bee A; Foster CS; Ke Y
    Int J Oncol; 2010 Jan; 36(1):69-76. PubMed ID: 19956834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.